可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Steffel J, Tanner FC. Biological effects of drug-eluting stents in the coronary circulation[J]. Herz, 2007, 32(4):268-273.
[2]Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization[J]. Circulation, 2007, 115(18):2435-2441.
[3]Jacobson JR. Statins in endothelial signaling and activation[J]. Antioxid Redox Signal, 2009, 11(4):811-821.
[4]尹志勇,魏丽萍,郝媛媛,等. LY333531对高糖所致心肌微血管内皮细胞通透性上调的拮抗作用[J]. 细胞与分子免疫学杂志, 2009, 25(4): 303-305.
[5]Miriuka SG, Rao V, Peterson M, et al. mTOR inhibition induces endothelial progenitor cell death[J]. Am J Transplant, 2006, 6(9):2069-2079.
[6]Asnaghi L, Bruno P, Priulla M, et al. mTOR: a protein kinase switching between life and death[J]. Pharmacol Res, 2004, 50(6):545-549.
[7]Butzal M, Loges S, Schweizer M, et al. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro[J]. Exp Cell Res, 2004, 300(1):65-71.
[8] Katsumoto M, Shingu T, Kuwashima R, et al. Biphasic effect of HMG-CoA reductase inhibitor, pitavastatin, on vascular endothelial cells and angiogenesis[J]. Circ J, 2005, 69(12):1547-1555.
[9]Urbich C, Dernbach E, Zeiher AM, et al. Double-edged role of statins in angiogenesis signaling[J]. Circ Res, 2002, 90(6):737-744.
[10]Weis M, Heeschen C, Glassford AJ, et al. Statins have biphasic effects on angiogenesis[J]. Circulation, 2002, 105(6):739-745.
[11] Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway[J]. J Clin Invest, 2001, 108(3):391-397.